Eco Friendly CBD OIL

The Best Eco Friendly CBD Oil

CBD OIL

A Key Piece to the Puzzle: Verano Holdings CEO George Archos Discusses AltMed Merger

by

<![CDATA[

Multistate cannabis operator Verano Holdings announced earlier this month that it would acquire and combine operations with AltMed in Florida and Arizona in a merger that will form one of the largest private cannabis companies in the U.S.

Verano has vertically integrated operations in 12 states, with 17 Zen Leaf dispensary locations and 440,000 square feet of cultivation. The company produces a variety of cannabis products under the Encore Edibles, Avexia and Verano brands, and operates across both adult-use and medical markets.

AltMed is a vertically integrated medical cannabis company with 27 dispensaries operating under the MÜV brand. The company also manages 220,000 square feet of cultivation space in Florida and 30,000 square feet in Arizona, where it is expanding by an additional 50,000 square feet to meet increased demand.

When the transaction closes, the companies will operate eight cultivation facilities and 44 dispensaries under the Verano brand across 14 states, with plans for 32 additional retail locations.

Here, Verano Holdings CEO George Archos shares insight into the strategy behind the merger, as well as how the two companies will integrate their operations to achieve their broader goals.

Melissa Schiller: Why was AltMed an attractive acquisition target?

George Archos: We call it more of a strategic merger. The founders of that company are staying on board. Florida and Arizona were two attractive markets for us, and we looked at everyone in the space and the AltMed team was one of the top performers in Florida. We have a similar culture. They have a great business [and] great people, so the fit was almost like Verano had built their business. They operate in a very similar fashion, so it was very intriguing for us. Both teams are very excited for the future. The teams are both staying on board from the Verano side and the AltMed side, so it’s a very complementary transaction. And as we move forward, it’s a key piece to our puzzle.

Photo courtesy of Verano Holdings
Verano’s cultivation facility in Albion, Ill.

MS: Why are Florida and Arizona appealing markets for Verano Holdings?

GA: We did not [have a presence in Florida or Arizona]. We divested our Florida assets in the Harvest transaction, so this is our re-entrance back into the market, [and it’s] the same with Arizona. It’s perfect for our footprint as well as teams.

Florida was always an attractive market for us. They have a great patient base, a great population and limited licenses. In Florida, you have to basically depend on yourself in order to succeed. It’s a vertically integrated business, so you have to produce all your own flower and all your own products to sell through your stores, which is something that we’re very good at, and so is AltMed. They’re great cultivators, great at processing, and now, we’ll be able to bring in our best-in-practice SOPs and our additional products and introduce them into that market.

Arizona is also a very well-established medical program. It’s exciting for us to enter that market. Like New Jersey, they just passed adult-use there, which will be implemented next year. It’s attractive for us and seems like an area where we get to bring our products to market, wholesale those across the Arizona industry, and we’ll be looking to increase our footprint there over time on the retail side.

MS: How does this merger fit in with Verano’s overall M&A or expansion strategy?

GA: It really fit into the two states that we wanted to add to our current portfolio. Right now, we’re only looking to add depth within our current footprint, so we’re not necessarily looking to expand into other states—it’s really adding more retail and/or cultivation in the current markets that we’re in. That’s really our M&A strategy today.

MS: How will Verano ultimately integrate AltMed into its existing operations?

GA: The big benefit of AltMed is we don’t really have any duplicative people. Their entire team is staying on board, our team is staying on board, and we’ll integrate as far as making sure our retail and cultivation SOPs are all similar. But the teams are all staying intact. All three founders on the AltMed side are staying on, so it’s a very complimentary transaction.

The MÜV brand will remain within those states. We will be bringing the Verano brand and products and flower into those markets over the next few quarters. It takes time to make that happen. But MÜV will stay intact in those states, and we will be bringing some of the MÜV products into our current footprint. [AltMed has] some very unique items in their portfolio of products that we can bring to some of our medical states.

MS: What are some of Verano’s shorter- and longer-term goals looking ahead?

GA: It’s really to keep doing what we’ve been doing. We’re going to continue to scale in the markets that we’re in. We’re going to continue to build on our cultivation and processing capacity. We’ll continue to build on our retail footprint. We have quite a few stores planned between both companies, so it’s really just executing on our operational strategy.

Editor’s Note: This interview has been edited for style, length and clarity.

]]>

Study Reveals Gaps in Knowledge of Cannabinoids in Frequent Cannabis Users

by

When cannabis was illegal in every state, it was difficult for consumers to access credible information about what they were consuming. The situation is now quite different.

In many states, you can purchase cannabis from knowledgeable budtenders eager to describe terpene and cannabinoid content. Websites devoted to science-based cannabis education, including our sister publications Terpenes & Testing and Extraction Magazine, are great sources as well.

However, a study found that many of today’s cannabis consumers still have little cannabinoid knowledge despite greater access and available education.

Researchers from the University of Buffalo and Michigan distributed a survey to participants at the 2019 Hash Bash, an annual cannabis advocacy event held in Ann Arbor, Michigan. The 24-item questionnaire asked the 472 participants who responded to report effective doses of cannabinoids.

Over two-thirds of the respondents reported using cannabis daily, with the majority using it for medical purposes. While most admitted a knowledge gap in effective dosages, their estimates proved to be far from accurate–in fact, the authors reported that “participants’ average estimates for high-tetrahydrocannabinol (THC) (52%) and high-cannabidiol (CBD) (53%), as well as low-THC (28%) and low-CBD (30%) [cultivars] of cannabis, were considerably higher than the currently accepted definition.”[1]

Interestingly, men, European Americans, and those enrolled in medical cannabis programs had a greater understanding of effective dosages.

The majority of participants reported that their own experience guided most of their opinions about cannabis rather than information from their medical provider or other trusted source.

Co-author R. Lorraine Collins, PhD noted in a press release: “Our results suggest the need for broad-based cannabis education programs to help advocates and the general public to better understand and manage their use of [cannabis].”

In fact, many educational programs are popping up online with the goal of education for consumers.

 Lead study author Daniel Kruger, PhD concluded, “We really have to educate people. This has very real consequences because these compounds have differential effects.”

Image Credit: Erin Stone

Image Source: https://pixabay.com/photos/marijuana-leaf-cannabis-leaf-5315560/

Reference

Kruger DJ, et al. Frequent cannabis users demonstrate low knowledge of cannabinoid content and dosages. Drugs: Education, Prevention and Policy. 2020:1-7.

Huge Turnout at Washington State Liquor and Cannabis Board QC Testing Hearing

by

Liberty Health Sciences, a vertically integrated medical marijuana company with operations in Florida, announced in a Nov. 19 press release that it has reached an agreement to settle a class-action suit. The “memorandum of understanding [is] regarding settlement of the securities class action that was commenced against it in the United States in 2019,” the release states.

The settlement figure is $1.8 million US, according to the release, which states: “The settlement is made without any admission or finding of liability and is subject to court approval. There is no assurance that the settlement agreement will receive court approval.”

An attorney representing Liberty wrote in a letter to the judge, overseeing the case in the U.S. District Court for New York’s Southern District, that “Plaintiffs anticipate filing a motion for preliminary settlement approval by January 8, 2021.”

RELATED: How to Raise Capital Without Running Afoul of the SEC

Investors alleged in their January 2019 complaint that Liberty violated securities law. They claimed that Liberty, headquartered in Toronto, Ontario, Canada, “has had longstanding ties” with Aphria, another Canadian cannabis company. Of the “Class Period” between June 28, 2018, and Dec. 3, 2018, the complaint states:

“Throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Liberty, in conjunction with Aphria, was involved in a scheme whereby numerous fraudulent acquisitions and transactions were made to provide undue benefits to both companies’ insiders; and (ii) as a result, Liberty’s public statements were materially false and misleading at all relevant times.”

Aphria announced that it sold off its Liberty stake in September 2018, according to the complaint. Then, Quintessential Capital Management and Hindenburg Research published the report “Aphria: A Shell Game with a Cannabis Business on the Side,” alleging a scheme by Aphria to acquire shell companies and sell them off at, as the legal complaint states, “artificially inflated prices.”

“On this news, Liberty’s stock fell $0.36, or nearly 34%, over the next two trading days to close at $0.70 on December 4, 2018,” the complaint stated.

Numerous investors joined the suit against Liberty, according to the complaint. “The members of the Class are so numerous that joinder of all members is impracticable,” it reads.

Proceeding court filings, including amended complaints from Liberty’s attorneys, continued to set forth these allegations and highlight the large numbers of people who allegedly lost money in 2018 because of this “scheme.”

Liberty has dispensary and delivery operations across Florida and also cultivates and processes cannabis, according to its website and the legal complaint. Liberty plans to expand its manufacturing and processing facility, located on a 387-acre parcel of land in Florida, to 490,000 square feet of cultivation space, according to a press release.

The INVEST in America Act Aims To Increase Access to Cannabis for Research

by

The US House of Representatives has proposed a new bill, entitled the Moving Forward Act, which would allow researchers to access cannabis in states where it is commercially available.

Cannabis researchers have been required to source cannabis samples from a federally licensed manufacturer located at the University of Mississippi, a considerable limitation to their work.

The changes appear in the form of a buried provision within the INVEST in America Act, which is a much larger piece of legislation aiming to reform national transportation, including implementing new transportation safety requirements, climate change reduction strategies, and extension of federal aid for various programs.

Another cannabis-related provision within the bill is to allow for the transportation of cannabis products across state lines, even in states that have not legalized cannabis markets. There is a caveat to this of course.

Under the Act, states will also be required to devise cannabis education programs to inform drivers about the dangers of driving while consuming cannabis. These programs are similar to drinking and driving reduction programs.

The highway safety provision has drawn criticism from cannabis law reform advocates who argue that such a provision unnecessarily equates cannabis with an increase in impaired driving.

Additional amendments/provisions to the bill, including testing wastewater for different substances, were proposed but shot down by legislators.

As of today, the INVEST in America Act has passed Congress and is currently awaiting approval from the Senate. If the bill passes the Senate, it will then be passed on to the next President for approval.

In all, despite the limitations, the Moving Forward Act within the INVEST in America Act has huge potential to improve multiple elements of the cannabis industry, marking a huge step forward in conducting much-needed, in-depth research on cannabis.

Image Credit: Azam Kamolov

Image Source: https://pixabay.com/users/azamkamolov-2854934/

Oregon Liquor Control Commission Approves Recreational Marijuana License Stipulated Settlements

by

Portland, OR — PRESS RELEASE — At its regular monthly meeting on Nov. 19, 2020, the Oregon Liquor Control Commission (OLCC) approved eight recreational marijuana license stipulated settlements. Additionally, the City of Portland’s Cannabis Policy Oversight Team (CPOT) provided the Commission with an update on the Portland Cannabis Program.

CPOT reviewed its efforts to make equity the center of all decision-making efforts related to cannabis regulation, including ensuring that patients should have access to cannabis for medicinal purposes. CPOT is also reworking its cannabis grant program to focus on distributed funding to BIPOC recipients.

OLCC staff provided assessments of how two ballot measures approved by Oregon voters earlier this month could impact the agency.

Measure 109, which establishes a program for the therapeutic use of psilocybin mushrooms, directs the Oregon Health Authority (OHA) to enter into an agreement with the OLCC to use the state’s Cannabis Tracking System (CTS) to prevent psilocybin diversion from therapy program. OLCC has initiated conversations with its CTS vendor the OLCC has deferred further action, until OHA, currently busy with the pandemic, can begin implementing the program.

One provision of Measure 110 reclassifies some drug convictions which will impact the evaluation process of OLCC licensee and permitee applicants. Currently, the OLCC rarely makes a license or permit decision based solely on drug convictions, but there are differences between the OLCC’s alcohol and recreational marijuana licensing and permitting criteria that will now be reconciled; this might require the OLCC to enter into rulemaking.

The Commission also ratified the following violation fines and suspensions based on stipulated settlements (detailed information on specific cases can be found here on the OLCC website):

LA MOTA (#28CC) in Portland will serve an 18-day recreational marijuana retailer license suspension OR pay a fine of $2,970 fine for two violations.

Licensee is: La Mota, LLC, Co-Licensee; Aaron Mitchell, Member; Rosa Cazares, Co-Licensee

VIBRANT HIGHS will surrender its marijuana processor license suspension for one violation.

Licensees are: OGX, LLC; Paul Luttrell, Member; Jonathan Showker, Member; Kathy Cook, Member

LA MOTA FRONT AVE in Portland will serve a nine-day recreational marijuana retailer license suspension OR pay a fine of $1,485 fine for one violation.

Licensees are: La Mota Front Ave, LLC, Co-Licensee; Aaron Mitchell, Member; Rosa Cazares, Co-Licensee

EVIO LABS MEDFORD in Medford will surrender its recreational marijuana laboratory license suspension for four violations.

Licensees are: Smith Scientific Industries, Inc.; Anthony Smith, President/Director/Stockholder; William Waldrop, Secretary/Director; EVIO, Inc., Stockholder; Lori Glauser, Director/Stockholder; William Waldrop, Director/Stockholder

MR NICE GUY RETAIL in Corvallis will serve a 10-day recreational marijuana retailer license suspension OR pay a fine of $3,630 fine for two violations.

Licensees are: MNG Holdings, LLC; Michael NG, Member; Patrick Martin, Member

MR NICE GUY RETAIL in Salem will pay a fine of $280 for one recreational marijuana retailer license violation.

Licensees are: MNG Holdings, LLC; Michael NG, Member; Patrick Martin, Member

NECTAR in Salem will serve a seven-day recreational marijuana retailer license suspension OR pay a fine of $1,155 fine for two violations.

Licensees are: Nectar Markets, LLC; Nectar Holdings, Inc., Member; Jeremy Pratt, President/Director/Stockholder; Jeffrey Johnson, Vice-President; Michael Olson, Secretary/Treasurer

ALBION FARMS will serve an 18-day recreational marijuana producer license suspension OR pay a fine of $2,970 fine for two violations.

Licensees are: MediRec, LLC; Vandaly Industries, Inc., Member; Eric Buckner, President

Fruit of the Earth Natural Health

by

Who they are: Fruit of the Earth runs a cannabis/hemp dispensary and online CBD store in Santa Fe, New Mexico. The CBD branch, known as Natural Health (also, the CBD and More Store), began in 2014 as the first in the state. The company adheres to organic cultivation to “honor the needs of our beautiful planet.” Packaging is generally recycled and/or made of biodegradable plant plastics. They even plant a tree for each purchase. Folks, that’s 90,000 trees to date. Talk about seeing the forest for the trees!

The CBD products come from Colorado hemp extracted using supercritical carbon dioxide—the “safe and superior method.” Although the website houses a page for third-party laboratory reports, they were not available at time of writing, so you should contact them to find out more. The company’s micronization process aims to bump bioavailability up “7-10 times” but the details are closely guarded.

Why they’re unique: Fruit of the Earth Natural Health strives to be eco-conscious, and their efforts pair uniquely with colorful product infusions.

What products they have: Tinctures, topicals, edibles, and softgels. There are lots of tinctures, so we’ll start there.

The first step in choosing a tincture is “microbotanica” or not—this refers to the micronization of CBD to increase bioavailability. As the company explains, “Less goes further, and you can truly FEEL THE DIFFERENCE!”

The tinctures come as full spectrum, broad spectrum, or isolate. Check out the micronized line with infused herbals for added umph. Happy Joints, for example, combines 400 mg CBD with devil’s claw, white willow bark, cat’s claw, and more. Cell Care features an uncommon blend of burdock root, sheep sorrel, turkey rhubarb root, and a number of other herbals “used for centuries to promote cellular recovery.”

Then there’s Calm, the potent purple tincture with lemon balm, lavender, and St. John’s Wort. Organic olive oil is the name of the tincture game. And this is just a glimpse—we don’t have the word count to cover all the bonus ingredients!

Several topical products are available with micronization, such as the Cedar & Pine Salve or the Lavender Salve.

The honey is sourced locally and infused with 250 mg or 500 mg CBD. Scrumptious. The CBD pet biscuits are suitable for humans and come in sweet potato sesame or peanut butter pumpkin.

Non-CBD fare includes a selection of medicinal mushrooms. Unlike the CBD softgels, these are housed in vegetarian capsules.

Bonus: If you’re in the Santa Fe area, stop by the physical store. Or give them a ring—the Fruit of the Earth Natural Health team is available and happy to answer questions!

Jushi Holdings Inc. Announces Significant Expansion of Pennsylvania Cultivation Facility

by

Portland, OR — PRESS RELEASE — At its regular monthly meeting on Nov. 19, 2020, the Oregon Liquor Control Commission (OLCC) approved eight recreational marijuana license stipulated settlements. Additionally, the City of Portland’s Cannabis Policy Oversight Team (CPOT) provided the Commission with an update on the Portland Cannabis Program.

CPOT reviewed its efforts to make equity the center of all decision-making efforts related to cannabis regulation, including ensuring that patients should have access to cannabis for medicinal purposes. CPOT is also reworking its cannabis grant program to focus on distributed funding to BIPOC recipients.

OLCC staff provided assessments of how two ballot measures approved by Oregon voters earlier this month could impact the agency.

Measure 109, which establishes a program for the therapeutic use of psilocybin mushrooms, directs the Oregon Health Authority (OHA) to enter into an agreement with the OLCC to use the state’s Cannabis Tracking System (CTS) to prevent psilocybin diversion from therapy program. OLCC has initiated conversations with its CTS vendor the OLCC has deferred further action, until OHA, currently busy with the pandemic, can begin implementing the program.

One provision of Measure 110 reclassifies some drug convictions which will impact the evaluation process of OLCC licensee and permitee applicants. Currently, the OLCC rarely makes a license or permit decision based solely on drug convictions, but there are differences between the OLCC’s alcohol and recreational marijuana licensing and permitting criteria that will now be reconciled; this might require the OLCC to enter into rulemaking.

The Commission also ratified the following violation fines and suspensions based on stipulated settlements (detailed information on specific cases can be found here on the OLCC website):

LA MOTA (#28CC) in Portland will serve an 18-day recreational marijuana retailer license suspension OR pay a fine of $2,970 fine for two violations.

Licensee is: La Mota, LLC, Co-Licensee; Aaron Mitchell, Member; Rosa Cazares, Co-Licensee

VIBRANT HIGHS will surrender its marijuana processor license suspension for one violation.

Licensees are: OGX, LLC; Paul Luttrell, Member; Jonathan Showker, Member; Kathy Cook, Member

LA MOTA FRONT AVE in Portland will serve a nine-day recreational marijuana retailer license suspension OR pay a fine of $1,485 fine for one violation.

Licensees are: La Mota Front Ave, LLC, Co-Licensee; Aaron Mitchell, Member; Rosa Cazares, Co-Licensee

EVIO LABS MEDFORD in Medford will surrender its recreational marijuana laboratory license suspension for four violations.

Licensees are: Smith Scientific Industries, Inc.; Anthony Smith, President/Director/Stockholder; William Waldrop, Secretary/Director; EVIO, Inc., Stockholder; Lori Glauser, Director/Stockholder; William Waldrop, Director/Stockholder

MR NICE GUY RETAIL in Corvallis will serve a 10-day recreational marijuana retailer license suspension OR pay a fine of $3,630 fine for two violations.

Licensees are: MNG Holdings, LLC; Michael NG, Member; Patrick Martin, Member

MR NICE GUY RETAIL in Salem will pay a fine of $280 for one recreational marijuana retailer license violation.

Licensees are: MNG Holdings, LLC; Michael NG, Member; Patrick Martin, Member

NECTAR in Salem will serve a seven-day recreational marijuana retailer license suspension OR pay a fine of $1,155 fine for two violations.

Licensees are: Nectar Markets, LLC; Nectar Holdings, Inc., Member; Jeremy Pratt, President/Director/Stockholder; Jeffrey Johnson, Vice-President; Michael Olson, Secretary/Treasurer

ALBION FARMS will serve an 18-day recreational marijuana producer license suspension OR pay a fine of $2,970 fine for two violations.

Licensees are: MediRec, LLC; Vandaly Industries, Inc., Member; Eric Buckner, President

MarijuaNuts – CBD Health and Wellness

by

Who they are: The average American eats about 6 pounds of peanuts a year. Why stop there? MarijuaNuts (trademark pending) offers “peanuts with a kick.” Forget gummies and candy. Peanuts pack healthy fat, protein, fiber, potassium, and calcium—now with a CBD twist.

The company is based in Denver, Colorado. It was founded by “avid snackers [who] love the outdoors.” Enter peanuts, a healthy snack option for active lifestyles. MarijuaNuts is a relatively new venture that aims to bring a unique product–CBD peanuts–into the edibles world.

Batch testing is published on the site for potency. This reveals that products contain CBD sans other cannabinoids, although the original concentrate source is full spectrum and thus tiny amounts of tetrahydrocannabinol (THC) remain. The site also mentions an outdoor-minded charity but doesn’t specify which one.

Why they’re unique: Let’s face it: CBD snacks are usually junk food. MarijuaNuts promises “enough protein to help you get thru your next adventure.” The company stands alone against an avalanche of gummies by specializing in infused peanuts and peanut butter.

What products they have: The single serving pack of peanuts pushes 1.7 ounces with 200 mg CBD. These can be purchased in party boxes of 3 or 6 packs for a true price discount. There’s also the bulk bag for a whopping 2,000 mg CBD. If classic salt seems too plain, fire things up with spicy Cajun.

Infused peanut butter is currently offered in a three-pack of individual servings with 100 mg CBD each. The ingredients are as simple as you’d expect: peanuts, peanut oil, butter, salt, and CBD oil.

Justin T. said: “…These peanuts are so good. I was relaxed for about a couple hours after I ate them. Definitely recommend to anyone who hasn’t had them.”

Bonus: Subscribe to the MarijuaNuts community for free samples! Fans should also definitely pick up one of their fun T-shirts.

Village Farms International’s Pure Sunfarms Receives Cannabis Research License for On-Site Sensory Evaluation from Health Canada

by

Portland, OR — PRESS RELEASE — At its regular monthly meeting on Nov. 19, 2020, the Oregon Liquor Control Commission (OLCC) approved eight recreational marijuana license stipulated settlements. Additionally, the City of Portland’s Cannabis Policy Oversight Team (CPOT) provided the Commission with an update on the Portland Cannabis Program.

CPOT reviewed its efforts to make equity the center of all decision-making efforts related to cannabis regulation, including ensuring that patients should have access to cannabis for medicinal purposes. CPOT is also reworking its cannabis grant program to focus on distributed funding to BIPOC recipients.

OLCC staff provided assessments of how two ballot measures approved by Oregon voters earlier this month could impact the agency.

Measure 109, which establishes a program for the therapeutic use of psilocybin mushrooms, directs the Oregon Health Authority (OHA) to enter into an agreement with the OLCC to use the state’s Cannabis Tracking System (CTS) to prevent psilocybin diversion from therapy program. OLCC has initiated conversations with its CTS vendor the OLCC has deferred further action, until OHA, currently busy with the pandemic, can begin implementing the program.

One provision of Measure 110 reclassifies some drug convictions which will impact the evaluation process of OLCC licensee and permitee applicants. Currently, the OLCC rarely makes a license or permit decision based solely on drug convictions, but there are differences between the OLCC’s alcohol and recreational marijuana licensing and permitting criteria that will now be reconciled; this might require the OLCC to enter into rulemaking.

The Commission also ratified the following violation fines and suspensions based on stipulated settlements (detailed information on specific cases can be found here on the OLCC website):

LA MOTA (#28CC) in Portland will serve an 18-day recreational marijuana retailer license suspension OR pay a fine of $2,970 fine for two violations.

Licensee is: La Mota, LLC, Co-Licensee; Aaron Mitchell, Member; Rosa Cazares, Co-Licensee

VIBRANT HIGHS will surrender its marijuana processor license suspension for one violation.

Licensees are: OGX, LLC; Paul Luttrell, Member; Jonathan Showker, Member; Kathy Cook, Member

LA MOTA FRONT AVE in Portland will serve a nine-day recreational marijuana retailer license suspension OR pay a fine of $1,485 fine for one violation.

Licensees are: La Mota Front Ave, LLC, Co-Licensee; Aaron Mitchell, Member; Rosa Cazares, Co-Licensee

EVIO LABS MEDFORD in Medford will surrender its recreational marijuana laboratory license suspension for four violations.

Licensees are: Smith Scientific Industries, Inc.; Anthony Smith, President/Director/Stockholder; William Waldrop, Secretary/Director; EVIO, Inc., Stockholder; Lori Glauser, Director/Stockholder; William Waldrop, Director/Stockholder

MR NICE GUY RETAIL in Corvallis will serve a 10-day recreational marijuana retailer license suspension OR pay a fine of $3,630 fine for two violations.

Licensees are: MNG Holdings, LLC; Michael NG, Member; Patrick Martin, Member

MR NICE GUY RETAIL in Salem will pay a fine of $280 for one recreational marijuana retailer license violation.

Licensees are: MNG Holdings, LLC; Michael NG, Member; Patrick Martin, Member

NECTAR in Salem will serve a seven-day recreational marijuana retailer license suspension OR pay a fine of $1,155 fine for two violations.

Licensees are: Nectar Markets, LLC; Nectar Holdings, Inc., Member; Jeremy Pratt, President/Director/Stockholder; Jeffrey Johnson, Vice-President; Michael Olson, Secretary/Treasurer

ALBION FARMS will serve an 18-day recreational marijuana producer license suspension OR pay a fine of $2,970 fine for two violations.

Licensees are: MediRec, LLC; Vandaly Industries, Inc., Member; Eric Buckner, President

How do people use CBD?

by

CBD is something that many people have heard about over recent years, but some have never got around to trying.

In the past, many people had never even heard of CBD, but there has been a lot of positive press and increased research that has put this product on the map. More and more people have come to realize and experience the benefits of CBD products over the past few years, and it can provide a huge range of benefits that aid health and wellness.

Another of the great things about CBD is that it comes in many different forms. As research and development have evolved, an ever-increasing range of products has come onto the market. This has made CBD more accessible, as people can find the perfect products for their needs, preferences, and budget. People have their own preferences when it comes to how to use CBD, and there are plenty of options to choose from. We will explore some of these methods in this article.

Some Methods You Can Use

There are various methods you can use if you want to try CBD for yourself. The right one for you will depend on a range of factors such as how much you want to spend, your personal preferences, and what you hope to achieve by using CBD. There are various options available from providers such as MedterraCBD. Some of the methods you can consider are:

Tinctures and Drops

A lot of people decide to take CBD in the form of drops and tinctures, and this is a popular method with newbies as well as season CBD users. When you use this method, you can look forward to total convenience and ease, as the drops and tinctures are very easy to use. When you take CBD in this form, you should hold the liquid under the tongue for around 90 seconds to enable it to take full effect and to enjoy maximum benefit.

Edibles Products

Another great option for those who are new to using CBD is edible products, and there are lots of different ones you can choose from. If you enjoy candy and sweet things, you will be able to enjoy the best of both worlds when you choose edible CBD products. You can choose from various options such as chews and gummies among other things. So, you can look forward to a little treat while also benefitting from the effects of CBD.

Topical CBD Products

Not everyone wants to or needs to take CBD orally – there are also topical CBD products you can use including creams, balms, and beauty products. If you are treating an area of inflammation, you could effectively use a topical product to better target the area that is affected. If you want to improve your hair or skin condition, you can use one of a range of skincare and haircare products. There are even bath additives that you can use.

CBD Capsules

One other option is CBD capsules, which makes it easy to take a pre-calculated dose of CBD conveniently and easily. You can get different strengths and quantities to suit your needs, and these are great to take with you on trips or to take on the go.

These are some of the top methods for taking CBD.

Original Article: https://www.bmmagazine.co.uk/business/how-do-people-use-cbd/